Skip to main navigation

Investors
News Releases
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
IR Resources

News Releases

News Releases

Year

October 5, 2021

Harpoon Therapeutics to Present Preclinical Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer

September 2, 2021

Harpoon Therapeutics to Participate in Three Upcoming Virtual Investor Conferences

August 5, 2021

Harpoon Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

August 3, 2021

Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences

June 4, 2021

Harpoon Therapeutics Provides Progress Update for TriTAC® Clinical Programs and ProTriTAC™ Platform

June 4, 2021

Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTAC® HPN424 at the 2021 ASCO Annual Meeting

May 19, 2021

Harpoon Therapeutics to Present Updated Interim Clinical Data for TriTAC® HPN424 at the 2021 ASCO Annual Meeting

May 6, 2021

Harpoon Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

April 28, 2021

Harpoon Therapeutics to Participate in Truist Securities Life Sciences Summit

April 10, 2021

Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Email Alerts

RSS Feeds

Contact IR

Search

© 2021. Harpoon Therapeutics, Inc. All rights reserved.

Search Investor Relations